White Coat and Masked Hypertension

Hypertension: A Companion to Braunwald's Heart Disease: Second Edition

Volumn , Issue , 2013, Pages 64-68

  Mancia, Giuseppe ^a   Bombelli, Michele ^a   Sega, Roberto ^a   Grassi, Guido ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901478600     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2766-1.00007-7     Document Type: Chapter

References (48)

1. Mancia G., De Backer G., Dominiczak A., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of European Society of Cardiology. J Hypertens 2007, 25:1105-1187.
2. Chobanian A.V., Bakris G.L., Black H.R., et al. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
3. Hypertension Pickering G. Definitions, natural histories and consequences. Am J Med 1972, 52:570-583.
4. Riva-Rocci S. Un nuovo sfigmomanometro. Gazzetta medica di torino 1896, 50:981-996.
5. Mancia G., Bertinieri G., Grassi G., et al. Effects of blood-pressure measurement by the doctor on patients' blood pressure and heart rate. Lancet 1983, 2:695-698.
6. Mancia G., Parati G., Pomidossi G., et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987, 9:209-215.
7. Parati G., Ulian L., Santucciu C., et al. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998, 31:1185-1189.
8. Parati G., Stergiou G.S., Asmar R., et al. ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008, 26:1505-1526.
9. Sega R., Trocino G., Lanzarotti A., et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study). Circulation. 2001, 104:1385-1392.
10. Pickering T.G., James G.D., Boddie C., et al. How common is white coat hypertension?. JAMA. 1988, 259:225-228.
11. Julius S., Mejia A., Jones K., et al. "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 1990, 16:617-623.
12. Mancia G., Facchetti R., Bombelli M., et al. Long-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension 2006, 47:846-853.
13. Verdecchia P., Palatini P., Schillaci G., et al. Independent predictors of isolated clinic ('white-coat') hypertension. J Hypertens 2001, 19:1015-1020.
14. Sega R., Cesana G., Milesi C., et al. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension 1997, 30:1-6.
15. Zakopoulos N.A., Kotsis V.T., VCh Pitiriga, et al. White-coat effect in normotension and hypertension. Blood Press Monit. 2002, 7:271-276.
16. Mancia G., Omboni S., Parati G., et al. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001, 19:1755-1763.
17. Parati G., Pomidossi G., Casadei R., et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens 1988, 6:481-488.
18. Mancia G., Zanchetti A. White-coat hypertension: Misnomers, misconceptions and misunderstandings. What should we do next?. J Hypertens 1996, 14:1049-1052.
19. Mancia G. White coat effect. Innocuous or adverse phenomenon?. Eur Heart J 2000, 21:1647-1648.
20. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994, 24:793-801.
21. Verdecchia P., Reboldi G.P., Angeli F., et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005, 45:203-208.
22. Ohkubo T., Kikuya M., Metoki H., et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005, 46:508-515.
23. Bobrie G., Chatellier G., Genes N., et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004, 291:1342-1349.
24. Pierdomenico S.D., Pannarale G., Rabbia F., et al. Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens 2008, 21:879-883.
25. Khattar R.S., Senior R., Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998, 98:1892-1897.
26. Fagard R.H., Cornelissen V.A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007, 25:2193-2198.
27. Gustavsen P.H., Hoegholm A., Bang L.E., et al. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003, 17:811-817.
28. Mancia G., Facchetti R., Bombelli M., et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 2009, 27:1672-1678.
29. Mancia G., Bombelli M., Facchetti R., et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009, 54:226-232.
30. Sega R., Facchetti R., Bombelli M., et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005, 111:1777-1783.
31. Weber M.A., Neutel J.M., Smith D.H., et al. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994, 90:2291-2298.
32. Mancia G., Bombelli M., Facchetti R., et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007, 49:1265-1270.
33. Sander D., Kukla C., Klingelhofer J., et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation. 2000, 102:1536-1541.
34. Kikuya M., Hozawa A., Ohokubo T., et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000, 36:901-906.
35. Pringle E., Phillips C., Thijs L., et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003, 21:2251-2257. for the Syst-Eur Investigators.
36. Selenta C., Hogan B.E., Linden W. How often do office blood pressure measurements fail to identify true hypertension? An exploration of white-coat normotension. Arch Fam Med 2000, 9:533-540.
37. Liu J.E., Roman M.J., Pini R., et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999, 131:564-572.
38. Pierdomenico S.D., Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2011, 24:52-58.
39. Hansen T.W., Jeppesen J., Rasmussen S., et al. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006, 19:243-250.
40. Fagard R.H., Van Den Broeke C., De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005, 19:801-807.
41. Björklund K., Lind L., Zethelius B., et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003, 107:1297-1302.
42. Perloff D., Sokolow M., Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983, 249:2793-2798.
43. Staessen J.A., Thijs L., Fagard R., et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539-546.
44. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000, 35:844-851.
45. White W.B. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit 1997, 2:47-51.
46. Fagard R.H., Staessen J.A., Thijs L., for the Systolic Hypertension in Europe Trial Investigators, et al. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension. J Hypertens 2004, 22:81-87.
47. Mancia G., Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004, 22:435-445.
48. Mancia G. Effective ambulatory blood pressure control in medical practice: good news to be taken with caution. Hypertension 2007, 49:17-18.